Correlation Between Health Biotchnology and Goldman Sachs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Health Biotchnology and Goldman Sachs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Health Biotchnology and Goldman Sachs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Health Biotchnology Portfolio and Goldman Sachs Small, you can compare the effects of market volatilities on Health Biotchnology and Goldman Sachs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Health Biotchnology with a short position of Goldman Sachs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Health Biotchnology and Goldman Sachs.

Diversification Opportunities for Health Biotchnology and Goldman Sachs

-0.32
  Correlation Coefficient

Very good diversification

The 3 months correlation between Health and Goldman is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Health Biotchnology Portfolio and Goldman Sachs Small in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Goldman Sachs Small and Health Biotchnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Health Biotchnology Portfolio are associated (or correlated) with Goldman Sachs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Goldman Sachs Small has no effect on the direction of Health Biotchnology i.e., Health Biotchnology and Goldman Sachs go up and down completely randomly.

Pair Corralation between Health Biotchnology and Goldman Sachs

Assuming the 90 days horizon Health Biotchnology is expected to generate 3.06 times less return on investment than Goldman Sachs. But when comparing it to its historical volatility, Health Biotchnology Portfolio is 1.66 times less risky than Goldman Sachs. It trades about 0.03 of its potential returns per unit of risk. Goldman Sachs Small is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  3,446  in Goldman Sachs Small on September 12, 2024 and sell it today you would earn a total of  803.00  from holding Goldman Sachs Small or generate 23.3% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Health Biotchnology Portfolio  vs.  Goldman Sachs Small

 Performance 
       Timeline  
Health Biotchnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Health Biotchnology Portfolio has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong forward indicators, Health Biotchnology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Goldman Sachs Small 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Goldman Sachs Small are ranked lower than 11 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Goldman Sachs may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Health Biotchnology and Goldman Sachs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Health Biotchnology and Goldman Sachs

The main advantage of trading using opposite Health Biotchnology and Goldman Sachs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Health Biotchnology position performs unexpectedly, Goldman Sachs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Goldman Sachs will offset losses from the drop in Goldman Sachs' long position.
The idea behind Health Biotchnology Portfolio and Goldman Sachs Small pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Fundamental Analysis
View fundamental data based on most recent published financial statements
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities